Spring 2024

Lipid Luminations: Lipid Management in Chronic Kidney Disease

Introduction Chronic kidney disease (CKD) ranks among the top five causes of global mortality, affecting approximately 35.5 million people in the United States (US).1,2 Despite being preventable and treatable, the prevalence of CKD and related mortality are on the rise, making it an important... more

Specialty Corner: Lipid Management in Pregnancy and Lactation

Introduction Normal pregnancy is characterized by physiologic increases in maternal levels of cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C). These lipoproteins are taken up by the placenta and support optimal fetal... more

Practical Pearls: Dyslipidemia Management in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Key points MASLD is a risk factor for atherosclerotic cardiovascular disease and is associated with cardiometabolic risk factors, such as obesity (adiposopathy), hypertension, insulin resistance, diabetes and dyslipidemia. The cornerstone of MASLD management is aggressive treatment of risk... more

Case Study: Incident Type 2 Diabetes Mellitus following Statin Initiation in Youth

Introduction The association of statin use, and incident type 2 diabetes (T2D) is well established in adults.1 Similar observations have not been reported in youth. Despite this association, the benefits of statins in preventing atherosclerotic cardiovascular disease (ASCVD) appear to outweigh... more

SWLA Chapter Update: Robust Participation

There has been robust participation among SWLA members in the National Lipid Association activities and outstanding contributions to the field of lipidology! Here are just a few highlights of what our productive group achieved in 2023! Planned by SWLA leadership, Christie Ballantyne, MD; Nicole... more